mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.9 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |